4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001193125-25-258664
Chief Scientific Officer gave up 5,644 shares (to pay taxes)
- Chief Scientific Officer acquired 19,200 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mahaney Paige Chief Scientific Officer | 2025-10-28 | Option exercise | +19,200 | 105,000 | D: show line 1 in the form | ||
| Mahaney Paige Chief Scientific Officer | 2025-10-28 | Shares withheld for taxes | −5,644 | $2.58 | $14,562 | 99,356 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…